Key facts
- It has raised $80K; the latest was Later Stage VC in Aug 2025.
- Notable investors include Tech Incubator Program for Startup, Asia2G Capital, Hanyang University Technology Holdings, Hyundai Motor, InfoBank — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Voinosis
- ·The full record, as it builds
Funding rounds
No funding rounds for Voinosis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Voinosis
Developer of an artificial intelligence voice analysis technology designed to diagnose diseases using linguistic characteristics of diseases. The company's technology collects voice data from patients who have diseases correlated with alzheimer's and creates a bio-database to detect dementia in its early stages, enabling healthcare industries to detect diseases and treat patients early.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2019
- Employees
- 21
- Website
- voinosis.com/
- Ownership
- Privately Held (backing)
Voinosis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Voinosis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Voinosis in its N-PORT filings yet. We sweep new filings monthly.